Hindustan Bio Sciences Ltd
Hindustan Bio Sciences Ltd: Q2 FY27 Un-Audited Results Publication Confirmed
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 03 Nov 2026, 01:42 PM IST · BSE ID: 193abd53-ceae-4f04-91fd-936ed6bf49da
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has formally announced the publication of its financial results for the second quarter of the current fiscal year.
🤖 AI Summary
- Hindustan Bio Sciences published un-audited financial results for the quarter ended September 30, 2026.
- Results were published in Hitech Edition (English) and The Praja Palana (Telugu) on November 3, 2026.
- Publication is pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- A copy of the published results is enclosed with the intimation.
- The financial results are also available on the company's website.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total Revenue (Q2 FY27)
Rs. 85.04 Lakhs
Total Revenue (Q2 FY26)
Rs. 0.86 Lakhs
9788.37
Profit/(Loss) for the period (Q2 FY27)
Rs. 31.04 Lakhs
Profit/(Loss) for the period (Q2 FY26)
Rs. (5.85) Lakhs
Earnings per equity share - Basic (Q2 FY27)
Rs. 0.30
Earnings per equity share - Basic (Q2 FY26)
Rs. (0.05)
Total Expenses (Q2 FY27)
Rs. 54.00 Lakhs
Total Expenses (Q2 FY26)
Rs. 6.71 Lakhs
704.77
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this publication intimation.
👤
Who Is Affected
All shareholders are affected as the publication confirms public disclosure of the company's Q2 FY27 financial performance.
🔍
Management Signal
Management is adhering to regulatory obligations by formally intimating the publication of financial results, as per Regulation 47 of SEBI LODR.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q3 FY27 un-audited financial results — assess sustained revenue and profit growth.
Any further board meeting outcomes detailing operational or strategic updates.
Annual General Meeting (AGM) updates — for strategic direction and future outlook.
LOW RISK
This filing is a routine regulatory compliance notification.
💡 Investor Takeaway
Hindustan Bio Sciences Ltd confirmed publication of its Q2 FY27 un-audited results, with Total Revenue at Rs. 85.04 Lakhs and Profit for the period at Rs. 31.04 Lakhs. This contrasts with a Total Revenue of Rs. 0.86 Lakhs and a loss of Rs. 5.85 Lakhs in Q2 FY26.
⚖️ Strengths & Concerns
✅ Positives
- Total Revenue for Q2 FY27 stood at Rs. 85.04 Lakhs, marking an increase compared to Rs. 0.86 Lakhs in Q2 FY26.
- Profit for the period in Q2 FY27 was Rs. 31.04 Lakhs, improving from a loss of Rs. 5.85 Lakhs in Q2 FY26.
⚠️ Concerns
- Other Income for Q2 FY27 was Rs. 0.00 Lakhs, indicating no non-operational income for the quarter.
- The company reported a Profit (Loss) for the period of Rs. (7.88) Lakhs for the full FY26, highlighting prior year losses.
📅 Company Track Record
Previous filings indicated Hindustan Bio Sciences Ltd's board approved Q2 FY27 results on October 31, 2026, where Profit After Tax was reported as Rs. 31.04 Lakhs. The company also announced a company secretary resignation on October 31, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What financial results did Hindustan Bio Sciences Ltd publish for Q2 FY27?
Hindustan Bio Sciences Ltd published un-audited results for the quarter ended September 30, 2026 (Q2 FY27), showing Total Revenue of Rs. 85.04 Lakhs and Profit for the period of Rs. 31.04 Lakhs.
When and where were Hindustan Bio Sciences Ltd's Q2 FY27 results published?
The Q2 FY27 un-audited results were published on November 3, 2026, in Hitech Edition (English language) and The Praja Palana (Telugu language) newspapers.
How does Hindustan Bio Sciences Ltd's Q2 FY27 revenue compare to the previous year?
Hindustan Bio Sciences Ltd's Total Revenue for Q2 FY27 was Rs. 85.04 Lakhs, significantly higher than Rs. 0.86 Lakhs reported for the comparable Q2 FY26 period.
What was the Earnings Per Share (EPS) for Hindustan Bio Sciences Ltd in Q2 FY27?
The Basic Earnings per equity share for Hindustan Bio Sciences Ltd was Rs. 0.30 for the quarter ended September 30, 2026 (Q2 FY27).
Questions based on this BSE filing only. For information purposes.